First Time Loading...

Starpharma Holdings Ltd
ASX:SPL

Watchlist Manager
Starpharma Holdings Ltd Logo
Starpharma Holdings Ltd
ASX:SPL
Watchlist
Price: 0.12 AUD Market Closed
Updated: May 5, 2024

Starpharma Holdings Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Starpharma Holdings Ltd
Net Income (Common) Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
C
CU6

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Starpharma Holdings Ltd
ASX:SPL
Net Income (Common)
-AU$8.4m
CAGR 3-Years
24%
CAGR 5-Years
6%
CAGR 10-Years
1%
Mayne Pharma Group Ltd
ASX:MYX
Net Income (Common)
AU$117.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Net Income (Common)
AU$157.1m
CAGR 3-Years
N/A
CAGR 5-Years
120%
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Net Income (Common)
-AU$14.6m
CAGR 3-Years
-17%
CAGR 5-Years
-3%
CAGR 10-Years
-24%
Probiotec Ltd
ASX:PBP
Net Income (Common)
AU$8.7m
CAGR 3-Years
29%
CAGR 5-Years
-11%
CAGR 10-Years
21%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Net Income (Common)
-AU$24.6m
CAGR 3-Years
-52%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Starpharma Holdings Ltd's Net Income (Common)?
Net Income (Common)
-8.4m AUD

Based on the financial report for Dec 31, 2023, Starpharma Holdings Ltd's Net Income (Common) amounts to -8.4m AUD.

What is Starpharma Holdings Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
1%

Over the last year, the Net Income (Common) growth was 47%. The average annual Net Income (Common) growth rates for Starpharma Holdings Ltd have been 24% over the past three years , 6% over the past five years , and 1% over the past ten years .